Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.

Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-25 · accession 0000899243-22-003414 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-01-27	2021-04-30+	MRVI	Dolan Christine	See Remarks	A - Grant	$22.95	+18.1K	18.1K	New	+$415.8K
D	2022-01-27	2022-01-25	MRVI	Dolan Christine	See Remarks	A - Grant	$0.00	+31.5K	31.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-04-30	A	A	916	$22.95	916	D	—	—
2	Common	Class A Common Stock	2021-10-31	A	A	203	$22.95	1,119	D	—	—
3	Common	Class A Common Stock	2022-01-25	A	A	17,000	—	18,119	D	—	—	(F2) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer.
4	Derivative	Employee Stock Option (Right to Buy)	2022-01-25	A	A	31,500	$0.00	31,500	D	$26.32 · — to 2032-01-25	31,500 Class A Common Stock	(F3) Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.